GENERATION BIO CO's ticker is GBIO and the CUSIP is 37148K100. A total of 96 filers reported holding GENERATION BIO CO in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $12,710,660 | -34.7% | 3,353,736 | -5.2% | 0.00% | -100.0% |
| Q2 2023 | $19,453,294 | +31.3% | 3,536,962 | +2.6% | 0.00% | – |
| Q1 2023 | $14,819,367 | +1.7% | 3,446,364 | -7.1% | 0.00% | – |
| Q4 2022 | $14,572,702 | -24.1% | 3,708,067 | +2.5% | 0.00% | -100.0% |
| Q3 2022 | $19,202,000 | -16.4% | 3,616,045 | +3.3% | 0.00% | 0.0% |
| Q2 2022 | $22,973,000 | -1.2% | 3,501,963 | +10.5% | 0.00% | 0.0% |
| Q1 2022 | $23,261,000 | +3.7% | 3,168,813 | +0.0% | 0.00% | 0.0% |
| Q4 2021 | $22,426,000 | -71.4% | 3,167,656 | +1.4% | 0.00% | -50.0% |
| Q3 2021 | $78,347,000 | +2.2% | 3,125,139 | +9.6% | 0.00% | 0.0% |
| Q2 2021 | $76,669,000 | -7.5% | 2,850,140 | -2.2% | 0.00% | 0.0% |
| Q1 2021 | $82,917,000 | +118.8% | 2,913,455 | +117.9% | 0.00% | +100.0% |
| Q4 2020 | $37,901,000 | +82.7% | 1,336,890 | +99.2% | 0.00% | 0.0% |
| Q3 2020 | $20,747,000 | +4972.6% | 671,243 | +3342.3% | 0.00% | – |
| Q2 2020 | $409,000 | – | 19,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Life Science Advisors, LLC | 8,278,876 | $58,614,000 | 5.38% |
| Yiheng Capital Management, L.P. | 1,975,146 | $13,984,000 | 0.71% |
| Artal Group S.A. | 2,814,191 | $19,924,000 | 0.54% |
| HARVARD MANAGEMENT CO INC | 510,354 | $3,613,000 | 0.34% |
| Bellevue Group AG | 3,872,180 | $27,416,000 | 0.28% |
| Casdin Capital, LLC | 1,324,275 | $9,376,000 | 0.26% |
| FARALLON CAPITAL MANAGEMENT LLC | 3,500,000 | $24,780,000 | 0.12% |
| BVF INC/IL | 189,050 | $1,338,000 | 0.05% |
| PDT Partners, LLC | 36,843 | $261,000 | 0.02% |
| GSA CAPITAL PARTNERS LLP | 17,739 | $126,000 | 0.02% |